Atlas Trials

Southern China Urology Cancer Consortium

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Southern China Urology Cancer Consortium

RecordFirmDate
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients (NCT02324803)Southern China Urology Cancer Consortium2014-07-01

Track Southern China Urology Cancer Consortium automatically

Every clearance here is in the API, with alerts when new ones post.